
© Fraunhofer ITWM
Dr. Jonas Flechsig (left) and Prof. Alexander Scherrer (right) from Fraunhofer ITWM are working on AI-based methods for personalized interventions in the EU project RELEVIUM, aiming to improve the quality of life of patients with advanced pancreatic cancer.
Pancreatic carcinoma is one of the most aggressive cancer types with a poor prognosis. The partners in the EU RELEVIUM project aim to improve palliative care and the quality of life of patients with advanced pancreatic cancer using digital tools and AI-assisted multimodal intervention. Researchers at the Fraunhofer Institute for Industrial Mathematics ITWM apply explainable artificial intelligence (XAI) methods to implement personalized treatment plans and enhance patients’ well-being and self-management capacity.
MORE
MORE

